Effectiveness of Chinese medicine formula Huashibaidu granule on mild COVID-19 patients: A prospective, non-randomized, controlled trial.

Authors:
Chen B; Xue Y; Jing H; Wang X; Zhu P and 3 more

Journal:
Integr Med Res

Publication Year: 2023

DOI:
10.1016/j.imr.2023.100950

PMCID:
PMC10121152

PMID:
37192979

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Integr Med Res

Abbreviation: Integr Med Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Integrative & Complementary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Acupuncture for response and complete pain relief time of acute renal colic: Secondary analysis of …
Wang XZ; Liu CZ; Wang LQ and 5 more (2024) - Transparency Score: 4/6
Acupuncture treatment for Hashimoto's thyroiditis: An exploratory randomized controlled trial.
Wang S; Yang C; Zeng W and 3 more (2024) - Transparency Score: 5/6
Traditional, complementary, and integrative medicine and artificial intelligence: Novel opportuniti…
Ng JY; Cramer H; Lee MS and 1 more (2024) - Transparency Score: 3/6
Acupuncture as an alternative or in addition to conventional treatment for chronic non-specific low…
Giovanardi CM; Gonzalez-Lorenzo M; Poini A and 10 more (2023) - Transparency Score: 3/6
Acupuncture for endometriosis: A systematic review and meta-analysis.
Giese N; Kwon KK; Armour M. (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
4/6
66.7% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors have no competing interests to declare."

Evidence found in paper:

"Funding This work was supported by the three-year action plan for the development of traditional Chinese medicine in Shanghai, NO. ZY (2021–2023)−0103 and the emergency research projects of traditional Chinese medicine for preventing and treating Novel coronavirus-infected pneumonia, NO. 2022ZYLCYJ05–1."

Evidence found in paper:

"Clinical trial registration Chinese Clinical Trial Registry, ChiCTR2200058668"

Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025